• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对与聚苯乙烯纳米颗粒偶联的登革热肽疫苗高度保守表位的四价免疫反应增强

Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles.

作者信息

Chan Yanqi, Jazayeri Seyed Davoud, Ramanathan Babu, Poh Chit Laa

机构信息

Centre for Virus and Vaccine Research, School of Science and Technology, Sunway University, Subang Jaya 47500, Malaysia.

Department of Biological Sciences, School of Science and Technology, Sunway University, Subang Jaya 47500, Malaysia.

出版信息

Vaccines (Basel). 2020 Jul 25;8(3):417. doi: 10.3390/vaccines8030417.

DOI:10.3390/vaccines8030417
PMID:32722368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563452/
Abstract

Vaccination remains the major approach to the prevention of dengue. Since the only licensed live attenuated vaccine (LAV) lacked efficacy against all four serotypes, other vaccine platforms, such as synthetic peptide vaccines, should be explored. In this study, four multi-epitope peptides (P1-P4) were designed by linking a universal T-helper epitope (PADRE or TpD) to the highly conserved CD8 T cell epitope and B cell epitope (B1 or B2) against all four DENV serotypes. The multi-epitope peptides were conjugated to polystyrene nanoparticles (PSNPs) and four nanovaccines (NP1-NP4) were constructed. Mice immunized with NP1-NP4 elicited significantly higher titers of IgG and neutralizing antibodies when compared to immunization with naked P1-P4. The immune responses in mice immunized with peptide vaccines were compared with nanovaccines using ELISA, ELISPOT, and a neutralization test based on FRNT. Among the four conjugated peptide nanovaccines, NP3 comprising the TpD T-helper epitope linked to the highly conserved B1 epitope derived from the E protein was able to elicit significant levels of IFN-γ and neutralizing antibodies to all four dengue serotypes. NP3 is a promising tetravalent synthetic peptide vaccine, but the selection of a more effective CD8 T cell epitope and adjuvants to further improve the immunogenicity is warranted.

摘要

疫苗接种仍然是预防登革热的主要方法。由于唯一获得许可的减毒活疫苗(LAV)对所有四种血清型均缺乏效力,因此应探索其他疫苗平台,如合成肽疫苗。在本研究中,通过将通用T辅助表位(PADRE或TpD)与针对所有四种登革病毒血清型的高度保守的CD8 T细胞表位和B细胞表位(B1或B2)连接,设计了四种多表位肽(P1-P4)。将多表位肽与聚苯乙烯纳米颗粒(PSNP)偶联,构建了四种纳米疫苗(NP1-NP4)。与用裸露的P1-P4免疫相比,用NP1-NP4免疫的小鼠产生的IgG和中和抗体滴度显著更高。使用ELISA、ELISPOT和基于FRNT的中和试验,比较了用肽疫苗免疫的小鼠与纳米疫苗的免疫反应。在四种偶联肽纳米疫苗中,包含与源自E蛋白的高度保守B1表位连接的TpD T辅助表位的NP3能够引发针对所有四种登革热血清型的显著水平的IFN-γ和中和抗体。NP3是一种有前景的四价合成肽疫苗,但需要选择更有效的CD8 T细胞表位和佐剂以进一步提高免疫原性。

相似文献

1
Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles.对与聚苯乙烯纳米颗粒偶联的登革热肽疫苗高度保守表位的四价免疫反应增强
Vaccines (Basel). 2020 Jul 25;8(3):417. doi: 10.3390/vaccines8030417.
2
Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.合成的含有登革热病毒-2 包膜蛋白 III 区 B 细胞和 T 细胞表位的多肽可诱导 B 细胞和 T 细胞应答。
Vaccine. 2011 May 9;29(20):3695-702. doi: 10.1016/j.vaccine.2011.03.002. Epub 2011 Mar 17.
3
The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice.基于包膜蛋白结构域III的四价登革热疫苗在小鼠中引发的CD4 + T细胞免疫优势变化及保护作用
PLoS One. 2015 Dec 29;10(12):e0145717. doi: 10.1371/journal.pone.0145717. eCollection 2015.
4
Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 T Cell Responses.基于肽的纳米疫苗设计,针对妇科癌症的主要抗原,诱导 HLA-A2.1 限制性 CD8 T 细胞反应。
Front Immunol. 2018 Dec 21;9:2968. doi: 10.3389/fimmu.2018.02968. eCollection 2018.
5
Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.评价基于登革病毒包膜域 I 和 II 的四价和保守合成肽疫苗。
Virus Res. 2014 Aug 8;188:122-7. doi: 10.1016/j.virusres.2014.04.009. Epub 2014 Apr 21.
6
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.美国国立卫生研究院登革热疫苗引发的强效浆母细胞衍生抗体
J Virol. 2017 Oct 27;91(22). doi: 10.1128/JVI.00867-17. Print 2017 Nov 15.
7
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.绘制人类记忆B细胞和血清中和抗体对登革病毒4型感染及疫苗接种的反应图谱。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.
8
Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003.评估候选活病毒减毒登革热疫苗 TAK-003 诱导产生的细胞免疫的多样性和稳定性。
Front Immunol. 2019 Jul 31;10:1778. doi: 10.3389/fimmu.2019.01778. eCollection 2019.
9
Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.引发交叉中和抗体的合成B细胞表位:未来登革热疫苗的策略
PLoS One. 2016 May 25;11(5):e0155900. doi: 10.1371/journal.pone.0155900. eCollection 2016.
10
Optimization of Surface Display of DENV2 E Protein on a Nanoparticle to Induce Virus Specific Neutralizing Antibody Responses.优化登革热病毒 2 型 E 蛋白在纳米颗粒上的表面展示以诱导病毒特异性中和抗体反应。
Bioconjug Chem. 2018 May 16;29(5):1544-1552. doi: 10.1021/acs.bioconjchem.8b00090. Epub 2018 May 4.

引用本文的文献

1
Current status of the development of dengue vaccines.登革热疫苗的发展现状。
Vaccine X. 2024 Dec 17;22:100604. doi: 10.1016/j.jvacx.2024.100604. eCollection 2025 Jan.
2
A novel pan-epitope based nanovaccine self-assembled with CpG enhances immune responses against flavivirus.一种新型的基于泛抗原的纳米疫苗,与 CpG 自组装,增强了对黄病毒的免疫反应。
J Nanobiotechnology. 2024 Nov 28;22(1):738. doi: 10.1186/s12951-024-03031-0.
3
An In Silico Design of a Vaccine against All Serotypes of the Dengue Virus Based on Virtual Screening of B-Cell and T-Cell Epitopes.

本文引用的文献

1
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.四价登革热疫苗在健康儿童和青少年中的功效。
N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.
2
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.针对保守病毒蛋白的通用流感疫苗的研发。
Vaccines (Basel). 2019 Nov 1;7(4):169. doi: 10.3390/vaccines7040169.
3
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.登革热疫苗在恒河猴中诱导产生的强效中和抗体针对多种表位。
基于B细胞和T细胞表位虚拟筛选的登革病毒全血清型疫苗的计算机辅助设计
Biology (Basel). 2024 Aug 30;13(9):681. doi: 10.3390/biology13090681.
4
DENV Peptides Delivered as Spherical Nucleic Acid Constructs Enhance Antigen Presentation and Immunogenicity in vitro and in vivo.球形核酸构建体递呈登革病毒肽增强体外和体内的抗原呈递和免疫原性。
Int J Nanomedicine. 2024 Sep 20;19:9757-9770. doi: 10.2147/IJN.S467427. eCollection 2024.
5
Revolutionizing Nipah virus vaccinology: insights into subunit vaccine development strategies and immunological advances.革新尼帕病毒疫苗学:亚单位疫苗开发策略与免疫学进展洞察
In Silico Pharmacol. 2024 Jul 27;12(2):69. doi: 10.1007/s40203-024-00246-9. eCollection 2024.
6
Boosting PRRSV-Specific Cellular Immunity: The Immunological Profiling of an Fc-Fused Multi-CTL Epitope Vaccine in Mice.增强猪繁殖与呼吸综合征病毒特异性细胞免疫:小鼠中一种Fc融合多细胞毒性T淋巴细胞表位疫苗的免疫分析
Vet Sci. 2024 Jun 15;11(6):274. doi: 10.3390/vetsci11060274.
7
Immunoinformatics and computational approaches driven designing a novel vaccine candidate against Powassan virus.免疫信息学和计算方法驱动设计一种针对波瓦桑病毒的新型候选疫苗。
Sci Rep. 2024 Mar 12;14(1):5999. doi: 10.1038/s41598-024-56554-9.
8
Immunoinformatics-aided rational design of a multi-epitope vaccine targeting feline infectious peritonitis virus.免疫信息学辅助设计靶向猫传染性腹膜炎病毒的多表位疫苗的合理设计。
Front Vet Sci. 2023 Dec 13;10:1280273. doi: 10.3389/fvets.2023.1280273. eCollection 2023.
9
Multi Epitope-Based Vaccine Design for Protection Against and SARS-CoV-2 Coinfection.基于多表位的疫苗设计以预防流感和 SARS-CoV-2 合并感染
Adv Appl Bioinform Chem. 2022 Aug 2;15:43-57. doi: 10.2147/AABC.S366431. eCollection 2022.
10
Nanovaccines against Animal Pathogens: The Latest Findings.针对动物病原体的纳米疫苗:最新研究成果
Vaccines (Basel). 2021 Sep 4;9(9):988. doi: 10.3390/vaccines9090988.
PLoS Pathog. 2019 Jun 6;15(6):e1007716. doi: 10.1371/journal.ppat.1007716. eCollection 2019 Jun.
4
Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.登革热病毒结构蛋白和非结构蛋白的高保守表位:通用疫苗靶点的候选者。
Gene. 2019 May 5;695:18-25. doi: 10.1016/j.gene.2019.02.001. Epub 2019 Feb 8.
5
Immunological basis for enhanced immunity of nanoparticle vaccines.纳米颗粒疫苗增强免疫的免疫学基础。
Expert Rev Vaccines. 2019 Mar;18(3):269-280. doi: 10.1080/14760584.2019.1578216. Epub 2019 Feb 14.
6
Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library.通过 scFv 突变文库的计算机筛选设计针对登革热包膜蛋白高度保守区的抗体。
PLoS One. 2019 Jan 10;14(1):e0209576. doi: 10.1371/journal.pone.0209576. eCollection 2019.
7
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.当在低温下生产时,登革热 2 型病毒样颗粒(VLP)疫苗可引发最高滴度的中和抗体。
Vaccine. 2018 Nov 29;36(50):7728-7736. doi: 10.1016/j.vaccine.2018.10.072. Epub 2018 Oct 28.
8
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.登革热血清阳性状态对登革热疫苗安全性和有效性的影响。
N Engl J Med. 2018 Jul 26;379(4):327-340. doi: 10.1056/NEJMoa1800820. Epub 2018 Jun 13.
9
Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.预防性单纯疱疹病毒 2 型疫苗佐以通用 CD4 T 细胞辅助肽可诱导小鼠长期的保护性免疫,以抵抗致死性攻击。
Int Immunopharmacol. 2018 Aug;61:100-108. doi: 10.1016/j.intimp.2018.05.024. Epub 2018 May 29.
10
Characterization of a murine model of non-lethal, symptomatic dengue virus infection.描述一种非致死性、有症状的登革病毒感染的小鼠模型。
Sci Rep. 2018 Mar 20;8(1):4900. doi: 10.1038/s41598-018-22618-w.